Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jul;24(7):431-4.
doi: 10.1155/2010/296584.

Canadian Digestive Health Foundation Public Impact Series: gastroesophageal reflux disease in Canada: incidence, prevalence, and direct and indirect economic impact

Richard N Fedorak  1 , Sander Veldhuyzen van Zanten, Ron Bridges
Affiliations
Review

Canadian Digestive Health Foundation Public Impact Series: gastroesophageal reflux disease in Canada: incidence, prevalence, and direct and indirect economic impact

Richard N Fedorak et al. Can J Gastroenterol. 2010 Jul.

Abstract
in English, French

The Canadian Digestive Health Foundation initiated a scientific program to assess the incidence, prevalence, mortality and economic impact of digestive disorders across Canada. The current article presents the updated findings from the study concerning gastroesophageal reflux disease - a condition that develops when the reflux of stomach contents causes troublesome symptoms and/or complications (Montreal definition).

La Fondation canadienne pour la promotion de la santé digestive a mis sur pied un programme scientifique dans le but de mesurer l’incidence, la prévalence, la mortalité et l’impact économique associés aux maladies digestives au Canada. Cet article présente les conclusions mises à jour de l’étude sur le reflux gastro-œsophagien, une maladie caractérisée par le reflux du contenu gastrique et qui occasionne des symptômes et/ou des complications ennuyeux (d’après la définition de Montréal).

PubMed Disclaimer

Figures

Figure 1
Figure 1
Gastroesophageal reflux disease-related mortalities per year categorized according to age group
Figure 2
Figure 2
Retail market ($) for over-the-counter indigestion and heartburn remedies in Canada according to year
See this image and copyright information in PMC

References

    1. Frank L, Kleinman L, Ganoczy D, et al. Upper gastrointestinal symptoms in North America: Prevalence and relationship to healthcare utilization and quality of life. Dig Dis Sci. 2000;45:809–18. - PubMed
    1. Armstrong D, Marshall JK, Chiba N, et al. Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults – update 2004. Can J Gastroenterol. 2005;19:15–35. - PubMed
    1. Bardhan KD. The role of proton pump inhibitors in the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 1995;9(Suppl 1):15–25. - PubMed
    1. Martinez SD, Malagon IB, Garewal HS, Cui H, Fass R. Non-erosive reflux disease (NERD) – acid reflux and symptom patterns. Aliment Pharmacol Ther. 2003;17:537–45. - PubMed
    1. Ruigomez A, Garcia Rodriguez LA, Wallander MA, Johansson S, Dent J. Comparison of gastro-oesophageal reflux disease and heartburn diagnoses in UK primary care. Curr Med Res Opin. 2006;22:1661–8. - PubMed

LinkOut - more resources